The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy

Diabetes is a major cause of visual impairment among working-age adults in the United States. The proliferative form of diabetic retinopathy is associated with severe vision loss (acuity <5/200). The standard treatment in proliferative diabetic retinopathy (PDR) is panretinal photocoagulation (PR...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Drugs in Context Ročník 7; s. 212532 - 10
Hlavní autori:	Zhao, Yue, Singh, Rishi P
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England BioExcel Publishing Ltd 13.08.2018
Predmet:	aflibercept angiogenesis inhibitors antibodies bevacizumab diabetic retinopathy humanized antibodies intravitreal injection monoclonal ranibizumab Review vascular endothelial growth factor A aflibercept bevacizumab antibodies monoclonal intravitreal injection angiogenesis inhibitors diabetic retinopathy vascular endothelial growth factor A humanized antibodies ranibizumab
ISSN:	1745-1981, 1740-4398, 1740-4398
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!